Literature DB >> 28466056

Differential expression of NADPH oxidase-2 (Nox-2) and nuclear factor-erythroid 2-related factor 2 (Nrf2) transcripts in peripheral blood mononuclear cells isolated from dengue patients.

Cleetus Cherupanakkal1, Vijayakumar Ramachadrappa1, Tamilarasu Kadhiravan2, Narayanan Parameswaran3, Subhash Chandra Parija4, Agieshkumar Balakrishna Pillai5, Soundravally Rajendiran1.   

Abstract

The role of oxidative stress in the pathogenesis of dengue infection is not completely known. A recent study reveals the involvement of oxidative stress responsive molecules in the generation of host immune responses to dengue virus in vitro. Objective of the present study was to analyse the changes in the expression of oxidant-antioxidant genes Nox-2 (NADPH oxidase) and Nrf2 (nuclear factor-erythroid 2-related factor 2) in patients with dengue during the early phase of infection compared to other febrile illness (OFI) cases and healthy controls using Real-time qPCR assay. The study enrolled 88 dengue patients, 31 OFI cases, and 63 healthy individuals as controls. Out of 88 dengue cases, 32 were classified as severe dengue cases (SD) and remaining 56 patients as non-severe dengue (NSD). Blood samples were collected firstly at the time of admission and a second sampling was done from the available individuals (38 dengue and 13 OFI cases) at the time of defervescence. Total RNA was extracted from the Peripheral blood mononuclear cells and the transcripts level of Nox-2 and Nrf2 were analysed by qPCR. On DOA, both Nox-2 and Nrf2 expression was found to be down regulated in dengue and OFI cases (P < 0.05) compared to healthy controls. Interestingly at defervescence, the transcript levels were found to be significantly increased in dengue cases unlike OFI, where no such increment was evidenced. From DOA to DOD, the study observed a signficant increase in the levels of Nox-2 transcripts (P < 0.05) both in SD and NSD cases. But a significant Nrf2 activation was not observed in SD cases as we found in NSD cases. Thus  a steady and significant increase in Nox-2 transcript level in severe, non-severe and secondary dengue infected groups observed in the current study supports the earlier reports on the involvement of anti-oxidant response in dengue severity. However further studies on its protein levels and mechanistic action would decipher the exact role of these potential molecules in the disease virulence.

Entities:  

Keywords:  Dengue; Nox-2; Nrf2; SD and NSD

Year:  2017        PMID: 28466056      PMCID: PMC5377867          DOI: 10.1007/s13337-017-0365-9

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  26 in total

1.  Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity.

Authors:  S Green; D W Vaughn; S Kalayanarooj; S Nimmannitya; S Suntayakorn; A Nisalak; R Lew; B L Innis; I Kurane; A L Rothman; F A Ennis
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

2.  Dengue hemorrhagic fever: comparison of patients with primary and secondary infections.

Authors:  Muhammad Khurram; Wajeeha Qayyum; Syed Jawad Ul Hassan; Shamaila Mumtaz; Hamama Tul Bushra; Muhammad Umar
Journal:  J Infect Public Health       Date:  2014-07-04       Impact factor: 3.718

3.  Dengue outbreak in Vellore, southern India, in 1968, with isolation of four dengue types from man and mosquitoes.

Authors:  R M Myers; M J Varkey; R Reuben; E S Jesudass
Journal:  Indian J Med Res       Date:  1970-01       Impact factor: 2.375

4.  Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload.

Authors:  Seiichi Oyadomari; Chi Yun; Edward A Fisher; Nicola Kreglinger; Gert Kreibich; Miho Oyadomari; Heather P Harding; Alan G Goodman; Hanna Harant; Jennifer L Garrison; Jack Taunton; Michael G Katze; David Ron
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

5.  Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins.

Authors:  Monica Carvajal-Yepes; Kiyoshi Himmelsbach; Stephanie Schaedler; Daniela Ploen; Janis Krause; Leopold Ludwig; Thomas Weiss; Karin Klingel; Eberhard Hildt
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

6.  Assessing the prognosis of dengue-infected patients.

Authors:  Scott B Halstead; Lucy Cs Lum
Journal:  F1000 Med Rep       Date:  2009-09-28

Review 7.  Nrf2 signaling in coordinated activation of antioxidant gene expression.

Authors:  Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

8.  Early molecular markers predictive of dengue hemorrhagic fever.

Authors:  Carlos E Calzavara-Silva; Ana L V Gomes; Rita C C Maia; Bartolomeu Acioli-Santos; Laura H V G Gil; Ernesto T A Marques
Journal:  An Acad Bras Cienc       Date:  2009-12       Impact factor: 1.753

Review 9.  Dengue and dengue hemorrhagic fever: management issues in an intensive care unit.

Authors:  Sunit Singhi; Niranjan Kissoon; Arun Bansal
Journal:  J Pediatr (Rio J)       Date:  2007-05       Impact factor: 2.197

10.  Economic and disease burden of dengue illness in India.

Authors:  Donald S Shepard; Yara A Halasa; Brij Kishore Tyagi; S Vivek Adhish; Deoki Nandan; K S Karthiga; Vidya Chellaswamy; Mukul Gaba; Narendra K Arora
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.